HRP20190563T1 - Kombinacijsko cjepivo protiv pcv/mycoplasma hyopneumoniae - Google Patents

Kombinacijsko cjepivo protiv pcv/mycoplasma hyopneumoniae

Info

Publication number
HRP20190563T1
HRP20190563T1 HRP20190563TT HRP20190563T HRP20190563T1 HR P20190563 T1 HRP20190563 T1 HR P20190563T1 HR P20190563T T HRP20190563T T HR P20190563TT HR P20190563 T HRP20190563 T HR P20190563T HR P20190563 T1 HRP20190563 T1 HR P20190563T1
Authority
HR
Croatia
Prior art keywords
pcv
combination vaccine
mycoplasma hyopneumonia
hyopneumonia
mycoplasma
Prior art date
Application number
HRP20190563TT
Other languages
English (en)
Croatian (hr)
Inventor
Gregory P. Nitzel
Jeffrey E. Galvin
John Keith GARRETT
James R. Kulawik Ii
Tracy L. RICKER
Megan Marie SMUTZER
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48182999&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20190563(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of HRP20190563T1 publication Critical patent/HRP20190563T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HRP20190563TT 2012-04-04 2013-04-03 Kombinacijsko cjepivo protiv pcv/mycoplasma hyopneumoniae HRP20190563T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261620175P 2012-04-04 2012-04-04
PCT/US2013/035088 WO2013152083A2 (en) 2012-04-04 2013-04-03 Pcv/mycoplasma hyopneumoniae combination vaccine
EP13718432.1A EP2833910B1 (en) 2012-04-04 2013-04-03 Pcv/mycoplasma hyopneumoniae combination vaccine

Publications (1)

Publication Number Publication Date
HRP20190563T1 true HRP20190563T1 (hr) 2019-05-17

Family

ID=48182999

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20140954AA HRP20140954A2 (hr) 2012-04-04 2013-04-03 Kombinirano cjepivo protiv pcv i bakterije mycoplasma hyopneumoniae
HRP20190563TT HRP20190563T1 (hr) 2012-04-04 2013-04-03 Kombinacijsko cjepivo protiv pcv/mycoplasma hyopneumoniae

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HRP20140954AA HRP20140954A2 (hr) 2012-04-04 2013-04-03 Kombinirano cjepivo protiv pcv i bakterije mycoplasma hyopneumoniae

Country Status (32)

Country Link
US (5) US9125885B2 (enExample)
EP (2) EP3508218A1 (enExample)
JP (1) JP6271503B2 (enExample)
KR (3) KR20150003259A (enExample)
CN (1) CN104334186B (enExample)
AR (1) AR090615A1 (enExample)
AU (1) AU2013243537B2 (enExample)
BR (1) BR112014024785B1 (enExample)
CA (1) CA2869594C (enExample)
CL (1) CL2014002675A1 (enExample)
CO (1) CO7160025A2 (enExample)
CR (1) CR20140437A (enExample)
CY (1) CY1121998T1 (enExample)
DK (1) DK2833910T3 (enExample)
ES (1) ES2721925T3 (enExample)
HR (2) HRP20140954A2 (enExample)
HU (1) HUE043322T2 (enExample)
LT (1) LT2833910T (enExample)
MX (2) MX336503B (enExample)
MY (2) MY174622A (enExample)
NI (1) NI201400119A (enExample)
PH (1) PH12014502251B1 (enExample)
PL (1) PL2833910T3 (enExample)
PT (1) PT2833910T (enExample)
RS (1) RS58481B1 (enExample)
RU (1) RU2615443C2 (enExample)
SI (1) SI2833910T1 (enExample)
TR (1) TR201904603T4 (enExample)
TW (1) TWI602574B (enExample)
UA (1) UA114503C2 (enExample)
WO (1) WO2013152083A2 (enExample)
ZA (1) ZA201406974B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9120859B2 (en) * 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
KR102355614B1 (ko) * 2012-12-28 2022-01-27 베링거잉겔하임베트메디카게엠베하 마이코플라스마 항원을 포함하는 면역원성 조성물
UA121193C2 (uk) 2012-12-28 2020-04-27 Бьорінгер Інгельхайм Ветмедіка Гмбх Спосіб одержання імуногенної композиції проти мікоплазми
DK2994162T3 (en) 2013-05-08 2021-06-21 Pharmgate Biologics Inc Vaccine for pcv2 og mycoplasma
CN104248759B (zh) * 2013-11-19 2017-05-10 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
ES2786194T3 (es) * 2013-12-03 2020-10-09 Intervet Int Bv Vacuna contra Lawsonia intracellularis y el circovirus porcino de tipo 2
BR112016012435A8 (pt) 2013-12-03 2018-01-30 Intervet Int Bv vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
WO2015179412A1 (en) * 2014-05-19 2015-11-26 Merial, Inc. Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (pedv)
WO2016091998A1 (en) * 2014-12-11 2016-06-16 Intervet International B.V. Process for ready-to-use pcv2/m.hyo combination vaccine
CN108883169A (zh) * 2016-03-23 2018-11-23 英特维特国际股份有限公司 针对pcv2和prrs病毒感染的皮内应用疫苗
WO2017162741A1 (en) * 2016-03-23 2017-09-28 Intervet International B.V. A combination vaccine against pcv2 virus and mycoplasma hyopneumoniae infection
US11065324B2 (en) 2016-12-23 2021-07-20 Intervet, Inc. Combination vaccine for swine
CN106668855B (zh) * 2017-02-03 2020-11-24 四川省华派生物制药有限公司 猪肺炎支原体灭活疫苗与猪瘟活疫苗组合疫苗及其制备方法
MX390682B (es) 2017-04-13 2025-03-21 Intervet Int Bv Vacunas que contienen patogenos de cerdo para uso no mixto asociado.
CN109010818B (zh) * 2017-06-09 2021-11-09 普莱柯生物工程股份有限公司 一种预防和/或治疗猪圆环病毒感染的二联疫苗组合物及其制备方法和应用
CN109125719B (zh) * 2017-06-19 2022-06-14 普莱柯生物工程股份有限公司 一种含猪圆环病毒3型、猪圆环病毒2型抗原的免疫原性组合物及其应用
CN109207502B (zh) * 2018-10-10 2021-08-10 浙江洪晟生物科技股份有限公司 猪支原体肺炎和猪圆环病毒2型重组蛋白及制备二联疫苗
CN109234418B (zh) * 2018-11-20 2021-08-13 湖南中净生物科技有限公司 一种鉴别猪肺炎支原体野毒株和疫苗株的引物、试剂盒和方法
CN112294953A (zh) * 2020-12-31 2021-02-02 北京科牧丰生物制药有限公司 一种pcv2型杆状病毒载体、猪肺炎支原体、副猪嗜血杆菌三联灭活疫苗及制备方法
KR102646305B1 (ko) * 2021-03-04 2024-03-13 주식회사 이노백 돼지 마이코플라스마균 및 돼지 써코바이러스 감염 예방을 위한 다가 백신 조성물
US20240415950A1 (en) * 2021-03-04 2024-12-19 Innovac Multivalent vaccine composition for prevention of porcine mycoplasma and porcine circovirus infections
CN120173827A (zh) * 2025-05-20 2025-06-20 首都儿科研究所 一种人源肺炎支原体培养用培养基及其制备方法和应用

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB228811A (en) 1924-11-04 1925-02-12 Congoleum Company Inc Improvements in stands or racks for displaying rolled merchandise
US4606918A (en) 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4681870A (en) * 1985-01-11 1987-07-21 Imre Corporation Protein A-silica immunoadsorbent and process for its production
CA1267087A (en) 1985-02-14 1990-03-27 Nicolaas Visser Synthetic immunogen
US5084269A (en) 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
ES2052685T3 (es) 1987-03-17 1994-07-16 Akzo Nv Metodo para producir un adyuvante libre.
US5252328A (en) 1987-03-26 1993-10-12 Martin Marietta Energy Systems, Inc. Mycoplasma hyopneumoniae antigen and uses therefor
EP0283840A3 (en) 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor
ZA888209B (en) 1987-11-03 1990-07-25 Syntex Inc Vaccine adjuvant
US4985243A (en) 1988-01-20 1991-01-15 Ml Technology Ventures, L.P. Composition and method for protecting against diseases caused by microorganisms
US5240706A (en) 1989-04-07 1993-08-31 Ml Technology Ventures, L.P. Intranasal administration of Mycoplasma hyopneumoniae antigen
ZA906806B (en) 1989-08-31 1991-06-26 Ici Australia Operations Plants
EP0597852B2 (en) 1990-05-29 2005-08-10 Wyeth Holdings Corporation Swine pneumonia vaccine and method for the preparation thereof
US6113916A (en) 1990-05-29 2000-09-05 American Cyanamid Company Method of enhancing cell mediated immune responses
US5695769A (en) 1990-06-13 1997-12-09 Pfizer Inc. Pasteurella multocida toxoid vaccines
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
CA2103460C (en) 1991-06-06 2000-09-26 Gert Wensvoort Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
CA2116348C (en) 1991-08-26 2001-07-03 James E. Collins Sirs vaccine and diagnosis method
EP0610250B2 (en) 1991-10-14 2008-10-29 Intervet International BV Porcine reproductive respiratory syndrome (prrs) vaccine and diagnostic
DE69232969T2 (de) 1991-11-15 2004-08-05 Pfizer Inc. Methode zur herstellung von gram-negativen bakteriellen vakzinen
FR2686097B1 (fr) 1992-01-14 1994-12-30 Rhone Merieux Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
US5338543A (en) 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5534256A (en) 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
US6773908B1 (en) 1992-10-30 2004-08-10 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US6251397B1 (en) 1992-10-30 2001-06-26 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same
US6592873B1 (en) 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
US6380376B1 (en) 1992-10-30 2002-04-30 Iowa State University Research Foundation Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US5695766A (en) 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
ES2074950B1 (es) 1993-09-17 1996-03-16 Iberica Cyanamid Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
ATE365049T1 (de) 1994-05-10 2007-07-15 Wyeth Corp Abgeänderter, verbesserter brsv lebend- impfstoff
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US5788962A (en) 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
US5820869A (en) 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
DE19601754A1 (de) 1996-01-19 1997-07-24 Hoechst Ag Dictyocaulus viviparus Antigen zur Diagnose des Lungenwurmbefalls und zur Vakzinierung
US5846735A (en) 1996-04-18 1998-12-08 University Of Iowa Research Foundation Hepatitis C virus Fc-binding function
GB9622159D0 (en) 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
JP2001515467A (ja) 1996-12-20 2001-09-18 ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム モラクセラ・カタラーリスのｕｓｐａ１及びｕｓｐａ２抗原
KR20010032493A (ko) 1997-11-26 2001-04-25 아이오와 스테이트 유니버시티 리서치 파운데이션, 인코퍼레이티드 재조합 미코플라스마 히오뉴모니아(Ｍｙｃｏｐｌａｓｍａｈｙｏｐｎｅｕｍｏｎｉａｅ) 백신
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US6342231B1 (en) 1998-07-01 2002-01-29 Akzo Nobel N.V. Haemophilus parasuis vaccine and diagnostic
CA2290220C (en) 1998-12-22 2013-11-19 Pfizer Products Inc. An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
US6632439B2 (en) 1999-09-29 2003-10-14 Novartis Animal Health, Inc. Fusobacterium necrophorum vaccine and method for making such vaccine
US6585981B1 (en) 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
US7018638B2 (en) 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
DK2842569T3 (da) 2001-07-02 2019-05-20 Zoetis Services Llc Vaccination i en dosis med Mycoplasma hyopneumoniae
JP2004537543A (ja) * 2001-07-02 2004-12-16 ファイザー・プロダクツ・インク マイコプラズマ・ハイオニューモニエ・ワクチンおよび牛におけるマイコプラズマ・ボビス低減方法
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
WO2004003161A2 (en) 2002-06-28 2004-01-08 Iowa State University Research Foundation, Inc. Immunogenic mycoplasma hyopneumoniae polypeptides
EP1651265B1 (en) * 2003-07-24 2008-04-23 Merial Limited Vaccine formulations comprising an oil-in-water emulsion
KR20070096019A (ko) 2005-01-13 2007-10-01 베링거잉겔하임베트메디카게엠베하 향상된 ｐｒｒｓ 백신
UA95458C2 (ru) * 2005-09-09 2011-08-10 Интервет Интернешонал Б.В. Вакцина против pcv-2 у mda-положительных поросят
EP1792996A1 (en) 2005-12-01 2007-06-06 Consejo Superior de Investigaciones Cientificas Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV)
CN102698263B (zh) * 2005-12-29 2016-07-06 贝林格尔.英格海姆维特梅迪卡有限公司 多价pcv2免疫原性组合物和制备此类组合物的方法
ES2553254T3 (es) * 2005-12-29 2015-12-07 Boehringer Ingelheim Vetmedica, Inc. Uso de una composición inmunogénica de PCV2 para reducir los síntomas clínicos en cerdos
ES2377576T3 (es) * 2006-04-10 2012-03-29 Intervet International Bv Vacuna contra microplasma PRRV
PL2007419T3 (pl) 2006-04-10 2012-09-28 Intervet Int Bv Szczepionka przeciwko mykoplazmie i PRRSV
RU2520087C2 (ru) * 2006-12-15 2014-06-20 Бёрингер Ингельхайм Ветмедика, Инк. Лечение свиней с помощью антигена pcv2
KR101225304B1 (ko) * 2007-11-06 2013-01-22 와이어쓰 엘엘씨 마이코플라스마 하이오뉴모니아에 비독성 항원보강된 살아있는 백신
EP2242511A4 (en) 2008-01-23 2012-10-24 Boehringer Ingelheim Vetmed IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
US8444989B1 (en) 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
EP2356132A2 (en) 2008-10-16 2011-08-17 Pfizer Inc. Torque teno virus (ttv) isolates and compositions
FI20096134A0 (fi) 2009-11-03 2009-11-03 Pulse Finland Oy Säädettävä antenni
ES2559445T3 (es) 2010-05-11 2016-02-12 Intervet International B.V. Vacuna contra Mycoplasma hyopneumoniae apta para la administración en presencia de anticuerpos de origen materno
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
HUE028877T2 (en) * 2010-08-27 2017-01-30 Intervet Int Bv Test of biological activity of vaccine formulation
UA108902C2 (uk) 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
BR112014022067B1 (pt) 2012-03-07 2022-05-31 Ceva Sante Animale Composição compreendendo antígeno e lipopolissacarídeo
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) * 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine

Also Published As

Publication number Publication date
RU2615443C2 (ru) 2017-04-04
CN104334186B (zh) 2018-11-13
US10206993B2 (en) 2019-02-19
SI2833910T1 (sl) 2019-05-31
WO2013152083A2 (en) 2013-10-10
US10668145B2 (en) 2020-06-02
AR090615A1 (es) 2014-11-26
ZA201406974B (en) 2016-07-27
ES2721925T3 (es) 2019-08-06
JP6271503B2 (ja) 2018-01-31
NI201400119A (es) 2015-03-05
TWI602574B (zh) 2017-10-21
EP2833910B1 (en) 2019-02-13
CR20140437A (es) 2014-11-10
CL2014002675A1 (es) 2014-12-12
WO2013152083A3 (en) 2013-12-19
MX336503B (es) 2016-01-21
CO7160025A2 (es) 2015-01-15
CN104334186A (zh) 2015-02-04
US20130266602A1 (en) 2013-10-10
EP3508218A1 (en) 2019-07-10
JP2015512449A (ja) 2015-04-27
HK1206609A1 (en) 2016-01-15
TW201345549A (zh) 2013-11-16
PH12014502251A1 (en) 2014-12-15
US20170216423A1 (en) 2017-08-03
MX2014012015A (es) 2014-11-10
US9649369B2 (en) 2017-05-16
KR20170051528A (ko) 2017-05-11
KR20180049221A (ko) 2018-05-10
RS58481B1 (sr) 2019-04-30
AU2013243537B2 (en) 2017-10-12
CA2869594A1 (en) 2013-10-10
LT2833910T (lt) 2019-04-25
US9125885B2 (en) 2015-09-08
US20190209673A1 (en) 2019-07-11
PL2833910T3 (pl) 2019-10-31
MY174622A (en) 2020-05-02
EP2833910A2 (en) 2015-02-11
MY199179A (en) 2023-10-19
KR102003620B1 (ko) 2019-07-24
CA2869594C (en) 2018-06-19
BR112014024785A2 (pt) 2017-07-11
CY1121998T1 (el) 2020-10-14
HRP20140954A2 (hr) 2015-01-30
PH12014502251B1 (en) 2014-12-15
US11154609B2 (en) 2021-10-26
PT2833910T (pt) 2019-05-23
TR201904603T4 (tr) 2019-04-22
HUE043322T2 (hu) 2019-08-28
AU2013243537A1 (en) 2014-10-09
KR20150003259A (ko) 2015-01-08
UA114503C2 (uk) 2017-06-26
US20200338187A1 (en) 2020-10-29
BR112014024785B1 (pt) 2021-06-08
DK2833910T3 (en) 2019-04-15
MX354759B (es) 2018-03-20
US20150283222A1 (en) 2015-10-08
RU2014140106A (ru) 2016-05-27

Similar Documents

Publication Publication Date Title
HRP20190563T1 (hr) Kombinacijsko cjepivo protiv pcv/mycoplasma hyopneumoniae
HRP20190466T1 (hr) Kombinacijsko cjepivo protiv pcv/mycoplasma hyopneumoniae/prrs
DK2833908T3 (da) Mycoplasma hyopneumoniae-vaccine
BR112015002839A2 (pt) dispositivo operacional
DE112013002177A5 (de) Röntgenvorrichtung
BR112015011600A2 (pt) dispositivo
FR2997014B1 (fr) Composition sterile dermo-injectable
BR112014033077A2 (pt) combinação de vacina.
BR112015008649A2 (pt) Aparelho
DK2806934T3 (da) Luftvejsanordning
EP2876161A4 (en) VACCINE
DK2721933T3 (da) Emulsion
EP2829281A4 (en) VACCINE AGAINST LIPOPOLYSACCHARIDES (LPS)
DK2994162T3 (en) Vaccine for pcv2 og mycoplasma
EP2931176A4 (en) Medical sling
PL2879970T3 (pl) Urządzenie do zawieszania
CL2015001659A1 (es) Composición inmunogénica que comprende antígenos de mycoplasma
EP2804626A4 (en) VACCINE BASED ON AUTOLOGOUS CANCER CELLS
DK2958935T3 (da) Vaccine
DE112013005349A5 (de) Schnelllauf-Sektionaltor
EP2822599A4 (en) VACCINE FORMULATION
ES1078393Y (es) Dispositivo masturbador
ES1078583Y (es) Dispositivo para proteccion de calzado
DK2823235T3 (da) Ventilationssystem
DE102012103770A8 (de) Fensterbankabschluss